Cyto-Facto Inc.

Corporate Identity・Mission

To improve lives in Japan and beyond by swift and reliable delivery of novel CGT (cell & gene therapy) products

News

2026/01/15【NEWS】Cyto-Facto Signs Letter of Intent with Steminent for Contract Manufacturing of Stemchymal

2025/07/16【NEWS】Cyto-Facto Selected for Regenerative CDMO Subsidy

2024/12/24【NEWS】The Signing ceremony for MOU between Cyto-Facto and Hoa Lam Shangri-La Healthcare (Vietnam)

2024/12/04【NEWS】Signing ceremony for MoU between Cyto-Facto Inc. and Thermo Fisher Scientific Japan

2024/06/12【NEWS】Publication Information

Past Publication Information